Henningsdorf, Germany

Anke Busemann

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Revotar Biopharmaceuticals Ag. Active years: 2011-2013.



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anke Busemann: Innovator in Pharmaceutical Applications

Introduction

Anke Busemann is a prominent inventor based in Henningsdorf, Germany. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on aromatic compounds. With a total of 2 patents, her research focuses on medical applications that can enhance therapeutic processes.

Latest Patents

Anke Busemann's latest patents include groundbreaking work on aromatic compounds and their use in medical applications. These patents detail pharmaceutical compositions that comprise at least one compound of specific formulas, along with a pharmaceutically acceptable carrier. The innovations aim to modulate in-vitro and in-vivo binding processes mediated by E-, P-, or L-selectin binding, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Anke has been associated with Revotar Biopharmaceuticals AG, where she has played a crucial role in developing new pharmaceutical solutions. Her expertise in the field has positioned her as a key figure in the company, contributing to its innovative projects and research initiatives.

Collaborations

Anke Busemann has collaborated with notable colleagues, including Ewald Aydt and Remo Kranich. These partnerships have further enriched her research and development efforts, leading to advancements in pharmaceutical applications.

Conclusion

Anke Busemann's work exemplifies the impact of innovation in the pharmaceutical industry. Her contributions through patents and collaborations continue to pave the way for new medical applications that can significantly benefit healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…